Amarin Corp Plc (AMRN)

[sts66]

What kind of idiotic government tries to plan out spending 3 yrs into the future? I just learned of this, can't help enlighten you - all I remember is that when negotiations started I read something that said if a new drug was estimated to cost the NHS $20m/yr or more it got special scrutiny and had a higher benefit/risk/cost bar to meet than cheaper drugs. Also, didn't you write that NHS is proposing or agreed to pay $126/scrip? KM said they were getting $152/script - did he lie or did the UK change their price? That's less than they get in the US, and KM said they would sell V at a premium to US pricing in the EU. Another management failure? IIRC AMRN abandoned Germany because they only were willing to pay around $125/mo for V, and KM claimed they didn't want to set a precedent with such a low cost as it would affect pricing in every other country - so if that UK price is accurate, we gave up Germany at a cost of $50M for nothing.